How Dismantling Welfare Continues the Legacy of Eugenics
By Audrey Farley,
The Washington Post
| 09. 17. 2019
In July, the Trump administration unveiled a plan to disqualify 3 million Americans from receiving food stamps. The proposal, which would eliminate automatic enrollment in the Supplemental Nutrition Assistance Program (SNAP) for families that receive other benefits, is just the latest measure to slash federal aid for low-income people. Critics are calling the SNAP cuts “cruel and inhumane,” warning that they will endanger the well-being of many families, who will go hungry without food assistance. The administration also supports Medicaid work requirements and lowering the poverty threshold to reduce beneficiaries.
Like previous cuts to the social safety net, this measure was preceded by a significant ($1.5 trillion) corporate tax cut, suggesting that the government is squeezing the poor to pay the rich. But welfare cuts have long served another purpose: population control.
Building on the flawed logic that providing support to the poor incentivizes poverty and encourages low-income people to reproduce to take advantage of social support, Trump touts the curtailment of SNAP as a backward way of combating poverty itself. In the past few decades, lawmakers across the political...
Related Articles
By Vittoria Vardanega, SWI swissinfo.ch | 02.13.2026
In recent years, sperm donation has produced family trees of unprecedented size, stretching across countries and, in some cases, continents. Stories of “mass donors” have captured public attention, most recently through the Netflix documentary series, The Man with 1,000 Kids...
By Jonathan D. Moreno, Hastings Center Bioethics Forum | 02.09.2026
When I began to write a book about bioethics and the rules-based international order, the idea that the world was facing the greatest geopolitical change since World War II was uncontroversial for those who were paying attention to such esoterica...
By Zachary Brennan, Endpoints News | 02.23.2026
The FDA is spelling out the details of a new pathway to help speed personalized cell and gene therapies to market for rare diseases.
Monday’s long-awaited draft guidance outlines the agency’s “plausible mechanism” framework, a pathway FDA Commissioner Marty Makary...
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...